Propeller Health Grabs 510(k) Clearance For Bronchodilator Sensor Upgrade
This article was originally published in The Gray Sheet
FDA cleared Propeller Health’s newest iteration of its bronchodilator sensor indicated to help monitor and control asthma, COPD, and other respiratory disease.
You may also be interested in...
Digital health startup Asthmapolis has changed its name to Propeller Health, reflecting its broader focus to include chronic obstructive pulmonary disease.
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.